Insights

Why the Mesoblast (ASX:MSB) share price is edging higher on Tuesday

The company is searching for a permeant replacement.
The post Why the Mesoblast (ASX:MSB) share price is edging higher on Tuesday appeared first on The Motley Fool Australia. –

The Mesoblast limited (ASX: MSB) share price is pushing ahead today following a change in the company’s leadership team.

At the time of writing, the allogeneic cellular medicines developer’s shares are up 2.58% to $1.99. In comparison, the All Ordinaires Index (ASX: XAO) is up 0.1% to 7,811 points.

What did Mesoblast announce?

Investors appear to be unfazed by the change in senior management, sending Mesoblast shares higher.

According to its release, Mesoblast advised that its chief financial officer (CFO), Josh Muntner will be leaving the company. This will take effect on 30 August 2021 following Mesoblast’s release of its full-year financial results.

Prior to the departure, Mr Muntner will work closely with the board and management to complete the FY21 financial statements. In addition, Mr Muntner will smooth the transition process in which Andrew Chaponnel will take over as interim CFO.

Management stated that Mr Chaponnel brings strong leadership skills over his past 9 years with Mesoblast. Initially, he served as group financial controller, with the last 3 years taking the helm as head of finance. Most notably, Mr Chaponnel has been involved with various corporate transactions and provided oversight of finance functions.

Mesoblast CEO, Silviu Itescu commented:

Josh has been a valuable member of our leadership team; we thank him for his contribution to Mesoblast and wish him well for the future. We are confident that Andrew’s experience in financial oversight and various corporate transactions will be of great benefit as he transitions to his new role.

About the Mesoblast share price

Over the last 12 months, Mesoblast shares have plummeted in value, sinking almost 60%. Year-to-date has fared better but still in negative territory, down 10%. The company’s share price is near its 52-week low of $1.70 reached in June.

At today’s price, Mesoblast has a market capitalisation of roughly $1.2 billion, with approximately 648 million shares on issue.

The post Why the Mesoblast (ASX:MSB) share price is edging higher on Tuesday appeared first on The Motley Fool Australia.

Should you invest $1,000 in Mesoblast right now?

Before you consider Mesoblast, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Mesoblast wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

Why Emerge Gaming, Imugene, Mesoblast, & Nick Scali shares are dropping

Why the Mesoblast (ASX:MSB) share price is dropping on Friday
These are the 10 most shorted ASX shares

ASX 200 Weekly Wrap: ASX shakes off lockdowns to rise higher

These were the worst performing ASX 200 shares last week

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!